X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (633) 633
cardiac & cardiovascular systems (471) 471
male (411) 411
female (407) 407
aged (356) 356
middle aged (338) 338
abridged index medicus (217) 217
mortality (217) 217
acute coronary syndromes (213) 213
heart attacks (208) 208
treatment outcome (198) 198
risk factors (182) 182
cardiovascular (178) 178
cardiology (164) 164
care and treatment (160) 160
electrocardiography (131) 131
coronary heart disease (126) 126
acute myocardial-infarction (125) 125
heart attack (118) 118
cardiac patients (116) 116
peripheral vascular disease (116) 116
prognosis (116) 116
drug therapy (110) 110
unstable angina (110) 110
platelet aggregation inhibitors - therapeutic use (105) 105
patient outcomes (99) 99
percutaneous coronary intervention (98) 98
myocardial infarction (95) 95
myocardial-infarction (95) 95
myocardial infarction - therapy (94) 94
coronary vessels (91) 91
cardiovascular disease (90) 90
angioplasty (89) 89
myocardial infarction - drug therapy (89) 89
time factors (89) 89
internal medicine (88) 88
risk assessment (86) 86
myocardial infarction - mortality (85) 85
united states (83) 83
cardiology and cardiovascular medicine (82) 82
management (80) 80
patients (79) 79
coronary angiography (77) 77
aged, 80 and over (76) 76
analysis (75) 75
prospective studies (74) 74
adult (72) 72
follow-up studies (72) 72
medicine, general & internal (71) 71
clinical trials (68) 68
clopidogrel (68) 68
clinical outcomes (67) 67
outcomes (67) 67
risk (67) 67
practice guidelines as topic (66) 66
registries (66) 66
acute coronary syndrome - drug therapy (64) 64
myocardial infarction - diagnosis (64) 64
acute coronary syndrome (62) 62
thrombolytic therapy (62) 62
heart failure (59) 59
transluminal angioplasty (57) 57
angioplasty, balloon, coronary (55) 55
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (55) 55
trial (55) 55
angina pectoris (53) 53
fibrinolytic agents - therapeutic use (53) 53
medical research (52) 52
therapy (52) 52
aha scientific statements (51) 51
anticoagulants (51) 51
aspirin (50) 50
research (50) 50
anticoagulants - therapeutic use (49) 49
coronary artery bypass (49) 49
hospitals (49) 49
incidence (49) 49
intervention (49) 49
retrospective studies (49) 49
stroke (49) 49
united states - epidemiology (49) 49
acute disease (48) 48
drug therapy, combination (48) 48
ticlopidine - analogs & derivatives (48) 48
health aspects (47) 47
stents (47) 47
survival analysis (47) 47
hospital mortality (46) 46
hospitalization (45) 45
american heart association (44) 44
medical colleges (44) 44
acute coronary syndrome - mortality (43) 43
ischemia (43) 43
association task-force (42) 42
randomized controlled trials as topic (42) 42
acute coronary syndrome - therapy (41) 41
biomarkers - blood (41) 41
diabetes (41) 41
myocardial infarction - physiopathology (41) 41
syndrome (41) 41
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10081, pp. 1799 - 1808
Summary Background Dual antiplatelet therapy (DAPT), aspirin plus a P2Y12 inhibitor, is the standard antithrombotic treatment following acute coronary... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | MANAGEMENT | MYOCARDIAL-INFARCTION | TICAGRELOR | STENT THROMBOSIS | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | INTERVENTION | SECONDARY PREVENTION | ANTIPLATELET THERAPY | Purinergic P2Y Receptor Antagonists - administration & dosage | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Myocardial Infarction - diagnostic imaging | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Coronary Angiography - methods | Adenosine - therapeutic use | Thrombolytic Therapy - methods | Ticlopidine - administration & dosage | Female | Myocardial Infarction - physiopathology | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Electrocardiography - methods | Purinergic P2Y Receptor Antagonists - therapeutic use | Rivaroxaban - therapeutic use | Double-Blind Method | Treatment Outcome | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Drug Therapy, Combination - methods | Factor Xa Inhibitors - therapeutic use | Myocardial Infarction - drug therapy | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Medical research | Medical colleges | Aspirin | Mortality | Cardiac patients | Clinical trials | Medicine, Experimental | Dosage and administration | Research institutes | France | Coronary heart disease | Analysis | Myocardial infarction | Therapy | Angiography | Disorders | Angina | Evidence-based medicine | Bleeding | Randomization | Motivation | Atherosclerosis | Safety | Drug therapy | Drug dosages | Heart diseases | Anticoagulants | Research & development--R&D | Strata | Coronary artery | Patients | Thrombosis | Thrombolysis | Inhibitors | Arteriosclerosis | Biomarkers | Infarction | Acute coronary syndromes
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2016, Volume 67, Issue 14, pp. 1674 - 1683
Journal Article
by Thygesen, Kristian and Alpert, Joseph S and Jaffe, Allan S and Simoons, Maarten L and Chaitman, Bernard R and White, Harvey D and Katus, Hugo A and Apple, Fred S and Lindahl, Bertil and Morrow, David A and Clemmensen, Peter M and Johanson, Per and Hod, Hanoch and Underwood, Richard and Bax, Jeroen J and Bonow, Robert O and Pinto, Fausto and Gibbons, Raymond J and Fox, Keith A and Atar, Dan and Newby, L. Kristin and Galvani, Marcello and Hamm, Christian W and Uretsky, Barry F and Gabriel Steg, Ph and Wijns, William and Bassand, Jean-Pierre and Menasché, Phillippe and Ravkilde, Jan and Ohman, E. Magnus and Antman, Elliott M and Wallentin, Lars C and Armstrong, Paul W and Januzzi, James L and Nieminen, Markku S and Gheorghiade, Mihai and Filippatos, Gerasimos and Luepker, Russell V and Fortmann, Stephen P and Rosamond, Wayne D and Levy, Dan and Wood, David and Smith, Sidney C and Hu, Dayi and Lopez-Sendon, José-Luis and Robertson, Rose Marie and Weaver, Douglas and Tendera, Michal and Bove, Alfred A and Parkhomenko, Alexander N and Vasilieva, Elena J and Mendis, Shanti and Baumgartner, Helmut and Ceconi, Claudio and Dean, Veronica and Deaton, Christi and Fagard, Robert and Funck-Brentano, Christian and Hasdai, David and Hoes, Arno and Kirchhof, Paulus and Knuuti, Juhani and Kolh, Philippe and McDonagh, Theresa and Moulin, Cyril and Popescu, Bogdan A and Reiner, Željko and Sechtem, Udo and Sirnes, Per Anton and Torbicki, Adam and Vahanian, Alec and Windecker, Stephan and Morais, Joao and Aguiar, Carlos and Almahmeed, Wael and Arnar, David O and Barili, Fabio and Bloch, Kenneth D and Bolger, Ann F and Bøtker, Hans Erik and Bozkurt, Biykem and Bugiardini, Raffaele and Cannon, Christopher and de Lemos, James and Eberli, Franz R and Escobar, Edgardo and Hlatky, Mark and James, Stefan and Kern, Karl B and Moliterno, David J and Mueller, Christian and Neskovic, Aleksandar N and Pieske, Burkert Mathias and Schulman, Steven P and Storey, Robert F and Taubert, Kathryn A and Vranckx, Pascal and Wagner, Daniel R and Classification Subcommittee and Heart Failure Subcommittee and Authors/Task Force Members Chairpersons and ECG Subcommittee and Imaging Subcommittee and Trials & Registries Subcommittee and Biomarker Subcommittee and Intervention Subcommittee and Global Perspective Subcommittee and ESC Committee for Practice Guidelines (CPG) and the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction and Epidemiology Subcommittee and Document Reviewers and Joint ESC ACCF AHA WHF Task Force and Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction
European heart journal, ISSN 1522-9645, 2012, Volume 33, Issue 20, pp. 2551 - 2567
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 12, pp. 1167 - 1176
Journal Article
by Thygesen, Kristian and Alpert, Joseph S and White, Harvey D and Biomarker Group: Allan S. Jaffe, Coordinator (USA), Fred S. Apple (USA), Marcello Galvani (Italy), Hugo A. Katus (Germany), L. Kristin Newby (USA), Jan Ravkilde (Denmark) and ECG Group: Bernard Chaitman, Co-ordinator (USA), Peter M. Clemmensen (Denmark), Mikael Dellborg (Sweden), Hanoch Hod (Israel), Pekka Porela (Finland) and Global Perspective Group: Philip A. Poole-Wilson, Coordinator (UK), Enrique P. Gurfinkel (Argentina), José-Luis Lopez-Sendon (Spain), Prem Pais (India), Shanti Mendis (Switzerland), Jun-Ren Zhu (China) and ESC COMMITTEE FOR PRACTICE GUIDELINES and Implementation Group: Lars C. Wallentin Coordinator (Sweden), Francisco Fernández-Avilés (Spain), Kim M. Fox (UK), Alexander N. Parkhomenko (Ukraine), Silvia G. Priori (Italy), Michal Tendera (Poland), Liisa-Maria Voipio-Pulkki (Finland) and Imaging Group: Richard Underwood, Coordinator (UK), Jeroen J. Bax (The Netherlands), George A. Beller (USA), Robert Bonow (USA), Ernst E. Van Der Wall (The Netherlands) and Joao Morais, Review Coordinator (Portugal), Sorin Brener (USA), Robert Harrington (USA), David Morrow (USA), Udo Sechtem (Germany), Michael Lim (Singapore), Marco A. Martinez-Rios (Mexico), Steve Steinhubl (USA), Glen N. Levine (USA), W. Brian Gibler (USA), David Goff (USA), Marco Tubaro (Italy), Darek Dudek (Poland), Nawwar Al-Attar (France) and Alec Vahanian, Chair (France), A. John Camm (UK), Raffaele De Caterina (Italy), Veronica Dean (France), Kenneth Dickstein (Norway), Gerasimos Filippatos (Greece), Christian Funck-Brentano (France), Irene Hellemans (The Netherlands), Steen Dalby Kristensen (Denmark), Keith McGregor (France), Udo Sechtem (Germany), Sigmund Silber (Germany), Michal Tendera (Poland), Petr Widimsky (Czech Republic), José Luis Zamorano (Spain) and TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), Joseph S. Alpert (USA), Harvey D. White (New Zealand) and Intervention Group: Jean-Pierre Bassand, Co-ordinator (France), William Wijns, Coordinator (Belgium), T. Bruce Ferguson (USA), Philippe G. Steg (France), Barry F. Uretsky (USA), David O. Williams (USA) and Clinical Investigation Group: Paul W. Armstrong, Coordinator (Canada), Elliott M. Antman (USA), Keith A. Fox (UK), Christian W. Hamm (Germany), E. Magnus Ohman (USA), Maarten L. Simoons (The Netherlands) and DOCUMENT REVIEWERS and ESC ACCF AHA WHF Task Force and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction and Sahlgrenska akademin and Institutionen för medicin, avdelningen för akut och kardiovaskulär medicin and Institute of Medicine, Department of Emergeny and Cardiovascular Medicine and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
Circulation (New York, N.Y.), ISSN 1524-4539, 2007, Volume 116, Issue 22, pp. 2634 - 2653
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2016, Volume 182, pp. 125 - 134
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 369, Issue 9565, pp. 907 - 919
Journal Article